PCLOF (PharmaCielo) Other Operating Expense: $0.05 Mil (TTM As of Dec. 2025)


What is PharmaCielo Other Operating Expense?

PharmaCielo PCLOF +11.51% Other Operating Expense is $0.05 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

PharmaCielo's Other Operating Expense for the three months ended in Dec. 2025 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $0.05 Mil.

PharmaCielo's quarterly Other Operating Expense increased from Jun. 2025 ($0.01 Mil) to Sep. 2025 ($0.04 Mil) but then declined from Sep. 2025 ($0.04 Mil) to Dec. 2025 ($0.00 Mil).

PharmaCielo's annual Other Operating Expense declined from Dec. 2021 ($1.36 Mil) to Dec. 2022 ($0.33 Mil) and declined from Dec. 2022 ($0.33 Mil) to Dec. 2023 ($0.27 Mil).

PharmaCielo Other Operating Expense Historical Data

* Premium members only.

The historical data trend for PharmaCielo's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Other Operating Expense Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial 0.76 3.25 1.36 0.33 0.27

PharmaCielo Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.02 0.01 0.04 0.00

PharmaCielo Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.05 Mil mean?
PharmaCielo (PCLOF) has a Other Operating Expense of $0.05 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on PharmaCielo and its competitors.
Is PharmaCielo's Other Operating Expense too high?
PharmaCielo's current Other Operating Expense is $0.05 Mil.
How does PharmaCielo's Other Operating Expense compare to ZTS and UTHR?
PharmaCielo's Other Operating Expense of $0.05 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on PharmaCielo and its competitors. PharmaCielo's current Other Operating Expense is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCielo stock overvalued right now?
Based on GuruFocus' analysis, PharmaCielo (PCLOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.10, compared to a current price of $0.05 — trading 52.1% below its estimated fair value. The current Other Operating Expense is $0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For PharmaCielo (PCLOF), the current Other Operating Expense is $0.05 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCielo Business Description

Other Exchanges PCLO:Canada
Address 82 Richmond Street East, Suite 805, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico and generates the majority of its revenue in the form of the Sale of Cannabis derivative products in America followed by Australia, Africa and Europe.